Compartir
Información de la revista
Número
Vol. 27. Núm. 5.(septiembre - octubre 2022)
Editorials
Challenges for hepatitis C in Mexico: a public health perspective towards 2030
Martha Carnalla, Sergio Bautista-Arredondo, Tonatiuh Barrientos-Gutiérrez
Ann Hepatol. 2022;27:100748
Open access
Opinions
The translational approach to liver transplantation
P. Constanza Arriola Benitez, M. Virginia Gentilini, Gabriel E. Gondolesi
Ann Hepatol. 2022;27:100747
Open access
Concise reviews
Possible roles of Golgi protein-73 in liver diseases
Meng-Yuan Liu, Lu Huang, Jiang-Feng Wu, Hong-Bing Zhang, Wen-Bing Ai, Rui-Tao Zhang
Ann Hepatol. 2022;27:100720
Open access
Clinical treatment of cholangiocarcinoma: an updated comprehensive review
Alessandra Elvevi, Alice Laffusa, Miki Scaravaglio, Roberta Elisa Rossi, Raffaella Longarini, Anna Maria Stagno, Laura Cristoferi, Antonio Ciaccio, ... Sara Massironi
Ann Hepatol. 2022;27:100737
Open access
Radiofrequency ablation and percutaneous ethanol injection versus radiofrequency ablation alone for hepatocellular carcinoma: a systematic review and meta-analysis
De-En Lu, Sheng-Wei Cheng, Yang-Sheng Lin, Mei-Wen Tu, Chia-Hsiang Lee, Chiehfeng Chen, Kee-Hsin Chen
Ann Hepatol. 2022;27:100729
Open access
Original articles
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany
Wolfgang Maximilian Kremer, Simon Johannes Gairing, Leonard Kaps, Esmeralda Ismail, Vasiliki Kalampoka, Max Hilscher, Maurice Michel, Ekkehard Siegel, ... Christian Labenz
Ann Hepatol. 2022;27:100719
Open access
Circ_0000291 contributes to hepatocellular carcinoma tumorigenesis by binding to miR-1322 to up-regulate UBE2T
Fang Wang, Shanshan Zhong, Chunjie Mao, Jingbo Jin, Haifeng Wang
Ann Hepatol. 2022;27:100722
Open access
A nomogram as an indirect method to identify sarcopenia in patients with liver cirrhosis
Marta Hernández-Conde, Elba Llop, Lucía Gómez-Pimpollo, Santiago Blanco, Luis Rodríguez, Carlos Fernández Carrillo, Christie Perelló, Marta López-Gómez, ... José Luis Calleja
Ann Hepatol. 2022;27:100723
Open access
Splenic vein embolization as a feasible treatment for patients with hepatic encephalopathy related to large spontaneous splenorenal shunts
Qiao Ke, Zhiyong Wang, Xinhui Huang, Ling Li, Weimin Wu, Linbin Qiu, Yubin Jiao, Yixing Xie, ... Wuhua Guo
Ann Hepatol. 2022;27:100725
Open access
Good post-transplant outcomes using liver donors after circulatory death when applying strict selection criteria: a propensity-score matched-cohort study
Margarita Fernández-de la Varga, Pablo del Pozo-del Valle, Sergio Béjar-Serrano, Rafael López-Andújar, Marina Berenguer, Martín Prieto, Eva Montalvá, Victoria Aguilera
Ann Hepatol. 2022;27:100724
Open access
The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study
Osama Hamid, Ahmed Eltelbany, Abdul Mohammed, Khaled Alsabbagh Alchirazi, Sushrut Trakroo, Imad Asaad
Ann Hepatol. 2022;27:100727
Open access
Circ_0005397 enhances hepatocellular carcinoma progression through miR-1283/HEG1
Haifeng Yu, Youde Liu, Yanna Wang, Yanfang Li, Jing Sun, Lijuan Liu
Ann Hepatol. 2022;27:100712
Open access
Position papers
Immune checkpoint and angiogenic inhibitors for the treatment of hepatocellular carcinoma: It takes two to tangle
Caecilia Sukowati, Loraine Kay D. Cabral, Claudio Tiribelli
Ann Hepatol. 2022;27:100740
Open access
Brief reports
Loneliness in adults awaiting liver transplantation at 7 U.S. transplant centers
Kacey A. Berry, Dorothea Kent, Srilakshmi Seetharaman, Randi Wong, Yara Mohamad, Frederick Yao, Maria Nunez-Duarte, Sharad I. Wadhwani, ... Jennifer C. Lai
Ann Hepatol. 2022;27:100718
Open access
Publique en
Annals of Hepatology
Affiliated societies
